R. Nayar

708 citations
14 papers · 563 indexed · h-index 9

Impact in

  • Hematology top 5%
    • Hematopoietic Stem Cell Transplantation
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 10%
    • Mesenchymal stem cell research
    • Chronic Lymphocytic Leukemia Research

Papers in

    • Hematopoietic Stem Cell Transplantation 4
    • Acute Myeloid Leukemia Research 2
    • Chronic Myeloid Leukemia Treatments 2
    • Cancer Treatment and Pharmacology 2
    • Cancer Cells and Metastasis 2

R. Nayar

14 papers receiving 541 citations

Peers

R. Nayar
Comparison fields: 5 of 59
  • Hematology 323
  • Genetics 127
  • Oncology 178
  • Immunology 131
  • Cancer Research 68
Replace N Belli with:
N Belli Italy
S. Peters United States
Mike Keeney Canada
Marlies E.H.M. Van Hoef United Kingdom
Marina Lafage France
Stern Ac Netherlands
Gianni Am Italy
Saul J. Sharkis United States
Mineo Kurokawa Japan
R.S. Hill United States
R. Nayar relative to N Belli Italy N Belli's profile →
Citations per field
00.5×
N Belli · 1×
Citations per year

Countries citing papers authored by R. Nayar

Since Specialization
Citations

This map shows the geographic impact of R. Nayar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Nayar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Nayar more than expected).

Fields of papers citing papers by R. Nayar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Nayar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Nayar. The network helps show where R. Nayar may publish in the future.

Co-authors

The 25 scholars most cited alongside R. Nayar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with R. Nayar Line = papers co-authored together R. Nayar links everyone, so they are left out of the graph.

All Works

14 of 14 papers shown
#Work
1 201112
2 200681
3 20042
4 20046
5 20041
6 1998149
7 19986
8 199717
9 199717
10 19968
11
Identification of CD34+ subsets after glycoprotease selection: engraftment of CD34+Thy-1+Lin- stem cells in fetal sheep.
199648
12
Optimizing the CD34+ and CD34+Thy-1+ stem cell content of peripheral blood collections.
199540
13
Sensitive detection and enumeration of CD34+ cells in peripheral and cord blood by flow cytometry.
1994167
14
Synergistic effect of stem cell factor with interleukin-3 or granulocyte-macrophage colony-stimulating factor on the proliferation of murine primitive hematopoietic progenitors.
19949

About R. Nayar

R. Nayar is a scholar working on Hematology, Oncology, Genetics, Microbiology and Hepatology, having authored 14 papers that have together received 563 indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (4 papers), Hematopoietic Stem Cell Transplantation (4 papers), Acute Myeloid Leukemia Research (2 papers), Neonatal Respiratory Health Research (2 papers), Cancer Treatment and Pharmacology (2 papers), Chronic Myeloid Leukemia Treatments (2 papers), Cancer Cells and Metastasis (2 papers) and Lymphoma Diagnosis and Treatment (2 papers). The work is most often cited by research in Hematology (323 citations), Genetics (127 citations), Oncology (178 citations), Immunology (131 citations) and Cancer Research (68 citations). R. Nayar has collaborated with scholars based in Canada, Italy and United States. Frequent co-authors include D. Robert Sutherland, Armand Keating, Alexander K. Stewart, A. Keith Stewart, Mark D. Minden, Jean Wang, JD Cashman, Tsvee Lapidot, Connie J. Eaves and Monica Doedens. Their work appears in journals such as Blood, Journal of Clinical Oncology, Pediatric Blood & Cancer, Clinical Cancer Research and Clinical Immunology Newsletter.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026